Advanced Search | View Cart | Check Out | 800.284.8433
Bookmark and Share

Cytopathology for the Practicing Pathologist

The Harvard Medical School, Department of Continuing Education
Course Director: Martha Bishop Pitman, MD

Cytopathology for the Practicing Pathologist is designed to be a unique interactive “multi-head-like” experience for the participant. It focuses on specific selected topics covering some of the most challenging areas of cytopathology using a case based format. Participants will have the tools needed to interpret common and uncommon cytological specimens encountered in everyday practice of pathology, including those procured by endoscopic ultrasound guided biopsy.


 
CREDITS Earn up to 14.5 AMA PRA Category 1 Credit
CE RELEASE March 17, 2008
CE EXPIRE March 17, 2010
 
Item No Media (Can't decide on a format?) Price Purchase
 
Special pricing for clinic-wide orders or for group subscriptions/purchases. Minimum order quantities apply for eligible discounts. For further information and pricing estimates, contact Jack O´ Toole at 1-800-952-0690 x3034. For all other sales inquiries, call 1-800-633-4743.
 

Topics & Speakers


Hepatocellular Carcinoma
and its Mimics
Martha Bishop Pitman, MD

FNA with Flow Cytometry for
Lymphoma Diagnosis in
Lymph Nodes
Rosemary H. Tambouret, MD

Basaloid and Myoepithelial
Proliferations of the
Salivary Glands
Lester J. Layfield, MD

FNA of Kidney Masses
Rosemary H. Tambouret, MD

Cytology of Glandular Lesions
of the Cervix
Joel S. Bentz, MD, MS

Non-Papillary Follicular Lesions
of the Thyroid
Lester J. Layfield, MD


Carcinomas of the Lung
Joel S. Bentz, MD, MS

Soft Tissue Tumors
Lester J. Layfield, MD

Selected Pitfalls in
Effusion Cytology
David C. Wilbur, MD

High Grade Squamous
Dysplasia on LBC
David C. Wilbur, MD

EUS-FNA of Solid
Pancreatic Masses
Martha Bishop Pitman, MD

EUS-FNA of Pancreatic Cysts
Martha Bishop Pitman, MD
COURSE DIRECTOR

Martha Bishop Pitman, MD
Associate Professor of Pathology
Harvard Medical School
Director, Fine Needle Aspiration Biopsy Service
Massachusetts General Hospital



FACULTY

Rosemary H. Tambouret, MD
Assistant Professor of Pathology
Harvard Medical School
Assistant in Pathology
Massachusetts General Hospital

David C. Wilbur, MD
Associate Professor of Pathology
Harvard Medical School
Director Cytopathology
Massachusetts General Hospital
GUEST FACULTY

Joel S. Bentz, MD, MS
Associate Professor (Clinical)
Division of Anatomic Pathology
Surgical Pathology and Cytopathology
University of Utah Health Sciences Center

Lester J. Layfield, MD
Professor, Pathology
University of Utah Health Sciences Center

 
 

Learning Objectives


At the conclusion of this program, participants should have the tools needed to interpret common and uncommon cytological specimens encountered in everyday practice of pathology, including those procured by endoscopic ultrasound guided biopsy.
 
 

Accreditation Statement


Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
 

Credit Designation


Harvard Medical School designates this educational activity for a maximum of 14.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release date: March 17, 2008 Credits expire: March 17, 2010

This educational activity is a DVD format. This post-graduate course in cytopathology is designed to be a unique interactive “multi-head-like” experience for the participant. It focuses on specific selected topics covering some of the most challenging areas of cytopathology using a case based format. It is estimated that it should take the average learner 14.5 hours, including completion of the evaluation, to conclude the activity.

CME credit is obtained upon successful completion of a self-assessment examination. A $30 processing fee must accompany the completed program evaluation.


 
 

Faculty Disclosure


Harvard Medical School has long held the standard that its continuing medical education courses be free of commercial bias. Now, in accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council on Continuing Medical Education, speakers and their spouses/partners, and planners have been asked to disclose any relationship they have to companies producing pharmaceuticals, medical equipment, prosthesis, etc. that might be germane to the content of their lectures.

Please note that now in accordance with recent policies from the ACCME, relationships of the person involved in the CME activity must include financial relationships of a spouse or partner.

In addition, faculty have been asked to describe any off label uses, they will discuss, of pharmaceuticals and devices for investigational or non-FDA approved purposes.

Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide the course director and registrants with information that might be of potential importance to their evaluation of a given talk. The full disclosure of faculty is listed in the syllabus.